Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study.

Tessa Noordermeer Roger E G Schutgens Chantal Visser Emma Rademaker Moniek P M de Maat Arend Jan Gerard Jansen Maarten Limper Olaf L Cremer Marieke J H A Kruip Henrik Endeman Coen Maas Bas de Laat Rolf T Urbanusnull null

Published in: Research and practice in thrombosis and haemostasis (2022)

Lupus anticoagulant on admission is strongly associated with thrombosis in critically ill patients with COVID-19, especially in patients aged less than 65 years.

Keyphrases

systemic lupus erythematosus
end stage renal disease
intensive care unit
pulmonary embolism
atrial fibrillation
venous thromboembolism
disease activity
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
rheumatoid arthritis
acute respiratory distress syndrome